Abstract
Globally emerging antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and extended spectrum beta-lactamase (ESBL)-producing Escherichia coli present increasing challenges to community transmission of infection. Recently, New Delhi metallo-beta-lactamase-1 (NDM-1) was identified; this enzyme makes bacteria resistant to most beta-lactam antibiotics which are used to treat antibiotic-resistant bacterial infections.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
